152 related articles for article (PubMed ID: 17567942)
1. Immunopharmacology of thymosin alpha1 and cytokine synergy.
Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
[TBL] [Abstract][Full Text] [Related]
2. Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy.
Naylor PH; Hadden JW
Ann N Y Acad Sci; 2010 Apr; 1194():162-8. PubMed ID: 20536465
[TBL] [Abstract][Full Text] [Related]
3. IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
Hadden JW; Verastegui E; Hadden E
Ann N Y Acad Sci; 2007 Sep; 1112():245-55. PubMed ID: 17600288
[TBL] [Abstract][Full Text] [Related]
4. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
[TBL] [Abstract][Full Text] [Related]
5. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
6. Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
Garaci E; Pica F; Matteucci C; Gaziano R; D'Agostini C; Miele MT; Camerini R; Palamara AT; Favalli C; Mastino A; Serafino A; Sinibaldi Vallebona P
Expert Opin Biol Ther; 2015; 15 Suppl 1():S31-9. PubMed ID: 26096345
[TBL] [Abstract][Full Text] [Related]
7. Thymosin alpha 1: from bench to bedside.
Garaci E; Favalli C; Pica F; Sinibaldi Vallebona P; Palamara AT; Matteucci C; Pierimarchi P; Serafino A; Mastino A; Bistoni F; Romani L; Rasi G
Ann N Y Acad Sci; 2007 Sep; 1112():225-34. PubMed ID: 17600290
[TBL] [Abstract][Full Text] [Related]
8. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
[TBL] [Abstract][Full Text] [Related]
11. Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.
Moody TW
Ann N Y Acad Sci; 2007 Sep; 1112():297-304. PubMed ID: 17567944
[TBL] [Abstract][Full Text] [Related]
12. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
[TBL] [Abstract][Full Text] [Related]
13. [Effects of thymosin alpha1 on immune effector molecules of mouse].
Li WY; Lu HM; Guo Q; Hu WM; Zhang ZD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):400-4. PubMed ID: 24941805
[TBL] [Abstract][Full Text] [Related]
14. Effect of a C-end rule modification on antitumor activity of thymosin α1.
Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
[TBL] [Abstract][Full Text] [Related]
15. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
Shao C; Tian G; Huang Y; Liang W; Zheng H; Wei J; Wei C; Yang C; Wang H; Zeng W
Int Immunopharmacol; 2013 Mar; 15(3):646-53. PubMed ID: 23352493
[TBL] [Abstract][Full Text] [Related]
16. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
[TBL] [Abstract][Full Text] [Related]
17. Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice.
Paul S; Sodhi A
Immunol Lett; 2002 Jul; 82(3):171-82. PubMed ID: 12036599
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
[TBL] [Abstract][Full Text] [Related]
19. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
Romani L; Bistoni F; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Zelante T; Moretti S; Rasi G; Garaci E; Puccetti P
Ann N Y Acad Sci; 2007 Sep; 1112():326-38. PubMed ID: 17495242
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory function of orally administered thymosin alpha1.
Chen XM; Jiang HL; Zhou LF; Pan XP; Hu ZR; Liu RH; Chen XM; Chen Z
J Zhejiang Univ Sci B; 2005 Sep; 6(9):873-6. PubMed ID: 16130188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]